| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
| 03/31/1994 | CA2144636A1 3,3'- disubstituted-1,3-dihydro-2h-pyrrolo [2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
| 03/31/1994 | CA2144539A1 Method of producing analgesia using neurotrophins |
| 03/31/1994 | CA2144419A1 Vpa-analogous antiepileptic agents |
| 03/31/1994 | CA2144039A1 Ureido-acetamides derivatives, preparation thereof and drugs containing same |
| 03/31/1994 | CA2107010A1 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz¬cd|indoles for treating motion sickness and vomiting |
| 03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
| 03/30/1994 | EP0589201A1 Di- and triazindeones |
| 03/30/1994 | EP0588917A1 Isoxazole and isothiazole compounds that enhance cognitive function |
| 03/30/1994 | CA2107026A1 Pharmaceutical compositions containing 1,5,6,7-tetrahydro-4h-indazol-4-ones, new 1,5,6,7-tetrahydro-4h-indazol-4-ones and processes for preparing them |
| 03/29/1994 | US5298522 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| 03/29/1994 | US5298520 Analgesics for treatment of migraine as antagonists for 5-HT1 receptors |
| 03/29/1994 | US5298257 Controlled transdermal nicotine delivery; anti-irritant |
| 03/29/1994 | CA2107180A1 Biotin amides, a process for their preparation and therapeutical compositions containing them as the active principles for the treatment of diabetes and relative complicating diseases |
| 03/29/1994 | CA2107060A1 Piperidine derivatives, their preparation and their application in therapeutics |
| 03/29/1994 | CA1328113C Process for the manufacture of novel unsaturated amino acid compounds |
| 03/29/1994 | CA1328109C Hydroxybutenolide derivatives, production and use thereof |
| 03/29/1994 | CA1328106C Anticholinergic compounds, pharmaceutical compositions and method of treatment |
| 03/29/1994 | CA1328077C Antipsychotic compositions containing dioxopiperidine derivatives |
| 03/26/1994 | CA2106840A1 Heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587789A1 Methods of treating injury to the central nervous system |
| 03/23/1994 | EP0587673A1 Derivatives of thiopyranopyrrole and preparation thereof |
| 03/23/1994 | EP0587670A1 Pcp receptor ligands and the use thereof |
| 03/23/1994 | EP0587645A1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity |
| 03/23/1994 | EP0587571A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 03/23/1994 | CN1084174A Method of preparation of physostigmine carbamate derivatives from physostigmine |
| 03/23/1994 | CN1084169A Compounds |
| 03/23/1994 | CN1084062A Composition for treating pain, method for treaing pain and composition for reinforcing pain relief action |
| 03/22/1994 | US5296596 Hexahydroazepine derivatives, a process for their preparation |
| 03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
| 03/22/1994 | US5296498 Guanidine compounds |
| 03/22/1994 | US5296491 Pyrazolo[4,3-c]pyridines and their use as serotonin reuptake inhibitors |
| 03/22/1994 | US5296479 Treating physiological or drug-induced psychosis or dyskinesia |
| 03/22/1994 | US5296477 Aminoalkyl benzoxazine and benzthiazine compounds having a high 5-HT1A affinity |
| 03/22/1994 | CA1327971C Benzopyran compound and its pharmaceutical use |
| 03/18/1994 | EP0575613A4 Pharmaceutical preparation of antistress, stress-preventive and nootropic action. |
| 03/18/1994 | EP0573565A4 Opiate receptor antagonist modulates hyperkinetic movement disorder. |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005663A1 Novel isoindolinone derivative, its preparation and pharmaceutical compositions containing same |
| 03/17/1994 | WO1994005655A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/17/1994 | WO1994005654A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | WO1994005648A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents |
| 03/17/1994 | WO1994005646A1 Optically active carboxamide derivative |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005319A1 Brain function ameliorant composition, learning capacity enhancer, mnemonic agent, dementia preventive, dementia curative, or functional food with brain function ameliorant effect |
| 03/17/1994 | WO1994005288A1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 03/17/1994 | WO1994005277A1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
| 03/17/1994 | WO1994005275A1 Method of preventing nmda receptor-mediated neuronal damage |
| 03/17/1994 | WO1994005274A1 Glycation inhibitor |
| 03/17/1994 | WO1994005265A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 03/17/1994 | WO1994005203A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
| 03/17/1994 | DE4231085A1 VPA-analoge Antiepileptika VPA-analog antiepileptic drugs |
| 03/17/1994 | CA2144423A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143744A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents |
| 03/17/1994 | CA2143449A1 Optically active carboxamide derivative |
| 03/17/1994 | CA2143010A1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
| 03/17/1994 | CA2142278A1 New isoindolinone derivative; process for preparing the same and pharmaceutical compositions containing it |
| 03/17/1994 | CA2141863A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/16/1994 | EP0587377A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease |
| 03/16/1994 | EP0587188A2 Aryl and heterocyclic substituted propenamide derivatives |
| 03/16/1994 | EP0587180A2 Aryl urea (Thiourea) and cyanoguanidine derivatives |
| 03/16/1994 | EP0587048A2 Heteroarenylpiperazines, a process for their preparation and their use as medicaments |
| 03/16/1994 | EP0586866A2 1,4,-Benzodioxane derivatives with pharmacologic properties |
| 03/16/1994 | EP0586553A1 Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586526A1 Aza-6-indole-derived compounds as benzodiazepine receptor ligands and drugs containing same |
| 03/16/1994 | EP0586525A1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives. |
| 03/16/1994 | EP0586513A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
| 03/16/1994 | EP0586486A1 Derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/16/1994 | EP0391971B1 Improving toxicity profiles in chemotherapy |
| 03/16/1994 | CN1083816A Method of preparation of physostigmine carbamate derivatives from eseretholes |
| 03/16/1994 | CN1083703A Pharmaceutical composition with functions of antialcohol, promoting change of energy, of mucosa of stomach, acidification, secretion, antradiation and anticholera |
| 03/16/1994 | CN1083702A Pharmacentical soft capsules containing lysne elonixiwate |
| 03/16/1994 | CN1024009C Pharmaceutical compounds |
| 03/15/1994 | US5294625 1-benzyl,4-((4-dialkylaminophenyl)carbonyl)piperidines |
| 03/15/1994 | US5294620 Hypotensive agents or compounds for cardiovascular disorders |
| 03/15/1994 | US5294619 Arylpiperidine derivatives |
| 03/15/1994 | CA1327805C Pilocarpine derivatives |
| 03/15/1994 | CA1327803C Derivatives of 1,2,5,6-tetrahydropyridin-3- carboxaldehyde oxime, their preparation process, their use as medicaments, and the compositions containing them |
| 03/15/1994 | CA1327800C Derivatives of aza-2-bicyclooctane-3-carboxylic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/15/1994 | CA1327799C Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it |
| 03/15/1994 | CA1327798C Imidazoquinoxaline compounds and their preparation and use |
| 03/15/1994 | CA1327797C Imidazoquinoxaline compounds and their preparation and use |
| 03/15/1994 | CA1327795C Antidepressants which are aryloxy inadanamines |
| 03/15/1994 | CA1327750C Therapeutic use of serotonin-antagonists |
| 03/12/1994 | CA2105959A1 Aryl urea (thiourea) and cyanoguanidine derivatives |
| 03/12/1994 | CA2105958A1 Aryl and heterocycle substituted propenamide derivatives |
| 03/11/1994 | CA2105598A1 Compounds useful as hypoglycemic agents and for treating alzheimer's disease |
| 03/10/1994 | CA2105708A1 Heteroarenylpiperazines, a process for their preparation and their use as medicaments |
| 03/09/1994 | EP0586191A1 Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride |
| 03/09/1994 | EP0585500A1 Diaryl piperazineacetamides as antimuscarinic agents |
| 03/09/1994 | EP0585296A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
| 03/09/1994 | EP0526588B1 Heterocyclic compounds and their preparation and use |
| 03/09/1994 | EP0439544B1 In vivo neurotrophic cytoprotective alcohols |
| 03/09/1994 | CN1083485A Benzothiazepine and benzoxazepine derivatives |
| 03/08/1994 | US5292906 Tricyclic steroid analogs |